| 461/636 | US=47 / Clín/Medica Trosko JE. From adults stem cells to cancer stem cells: oct-4 gene, cell-cell communication, and hormones during tumor promotion. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 36-58. ISBN 978-1-57331-699-5. GENE OCT3 / 4; JUNCOES COMUNICACAO INTERCELULAR; CELULAS-TRONCO ADULTAS; PROMOTOR DE TUMOR; CELULAS-TRONCO DO CANCER |
| 462/636 | US=47 / Clín/Medica Crivello A, Giacalone A, Vaglica M, Scola L, Forte GI, Macaluso MC, Raimondi C, Di Noto L, Bongiovanni A, Accardo A, Candore G, Palmeira S. Regulatory cytokine gene polymorphism and risk of colorectal carcinoma. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 98-103. ISBN 978-1-57331-699-5. RISCO DE CARCINOMA COLORRETAL; CANCER COLORRETAL; POLIMORFISMO DO GENE; TGF-B1; IL-10 |
| 463/636 | US=47 / Clín/Medica Scola L, Vaglica M, Crivello A, Palmeri L, Forte GI, Macaluso MC, Giacalone A, Di Noto L, Bongiovanni A, Candore G, Caruso C, Lio D, Palmeri S. Cytokine gene polymorphisms and breast cancer susceptibility. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 104-9. ISBN 978-1-57331-699-5. |
| 464/636 | US=47 / Biol/Mol Hayes DN, Meyerson M. Microarray approaches to gene expression analysis. In: Coleman WB, Tsongalis GJ. Molecular diagnostics: for the clinical laboratorian. 2ª ed. Totowa: Humana Press, 2006. p. 121-48. ISBN 1-58829-356-4. DIAGNOSTICO MOELCULAR; MICROARRAY; ANALISE DE EXPRESSAO GENICA; PLATAFORMA DE MICROARRAY DE DNA; MATRIZES DE OLIGONUCLEOTIDOS; PROTEOMICOS |
| 465/636 | US=55 / Biol/Mol Gojkovic Z, Karlsson A. Purine and pyrimidine-based analogs and suicide gene therapy. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 403-39. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. PURINA; ANALOGOS DE PIRIMIDINA-BASE; TERAPIA DE GENE SUICIDA; ACICLOVIR; CITOSINA DESAMINASE; DESOXINUCLEOSIDO QUINASE; SISTEMA DE ENTREGA DE DROGA; FLUOROCITOSINE; GANCICLOVIR; TERAPIA GENICA; TIMIDINA QUINASE DO HERPES; GENES SUICIDAS; TIMIDINA QUINASE |
| 466/636 | US=55 / Biol/Mol Direcks WGE, Lammertsma AA, Molthoff CFM. 3-deoxy-3-fluorothymidine as a tracer of proliferation in positron emission tomographyPurine and pyrimidine-based analogs and suicide gene therapy. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 441-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. 3-DESOXI-3-FLUOROTIMIDINA; MARCADOR DE PROLIFERACAO; TOMOGRAFIA POR EMISSAO DE POSITRONS |
| 467/636 | US=61 / Câncer Lunt SJ, Hill RP. Physiological resistance: tumor oxygenation and treatment response. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 43-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. HIPOXIA TUMOR; HIF-1; MARCADORES DE HIPOXIA; DROGAS BIORREDUTIVA; DIRIGIDO GENE-ENZIMA PRO-DROGA TERAPEUTICA |
| 468/636 | US=61 / Câncer Kee K, Green JE. Clinical aspects of resistance: molecular profiling in breast cancer. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 559-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. CANCER DE MAMA; PERFIL DE EXPRESSAO DO GENE; MICROARRAY; ANALISE DA SEQUENCIA DE OLIGONUCLEOTIDO MATRIZ; GENOMICA; ALVOS TERAPEUTICOS |
| 469/636 | US=8 / Fumo/Câncer Muller T, Gebel S. Cigarette smoke-induced redox signaling and gene expression. in In vitro and Vivo models. In: Halliwell BB, Poulsen HE. Cigarette smoke and oxidative stress. New York: Springer, 2006. p. 75-111. ISBN 978-3-540-31410-3. |
| 470/636 | Câncer Krepischi ACV, Capelli LP, Carvalho FF, Heck B, de Camargo B, Rosenberg C. A de novo em ~1.3 Mb microdeletion at 17q11.2 associated with Neurofibromatosis-Noonan syndrome. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.4, p. 153-5, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(4)p.153-5.pdf |
| 471/636 | US=79 / Imagem Hall EJ, Giaccia AJ. Gene therapy. In: ___. Radiobiology for the radiologist. 6ª ed. Philadelphia: Lippincott Willians & Wilkins, 2006. p. 432-9. ISBN 978-0-78-17-4151-4. TERAPIA GENICA; VETORES VIRAIS; TERAPIA DO GENE SUICIDA; VIRUS CITOTOXICOS; DEFICIENCIA DO P53; IMUNOLOGIA MOLECULAR; VACINA; GENES SUPRESSORES DE TUMOR; VIAS DE TRANSDUCAO DE SINAL |
| 472/636 | US=32 / Ginecologia Síndrome de insensibilidade ao androgênio. In: Smith RP. Ginecologia e obstetrícia de Netter. Porto Alegre (RS): Artmed, 2005. p. 358-60. ISBN 85-363-0165-1. AUSENCIA DO GENE NO CROMOSSOMO X; ALTERACOES GENETICAS; INSENSIBILIDADE DO ANDROGENIO |
| 473/636 | US=21 / Cab/Pesc Iskander A, Yoo GH. Gene therapy for patients with head and neck cancer. In: Adelstein JD. Squamous cell head and neck cancer: recent clinical progress and prospects for the future. Totowa: Humana Press, 2005. p. 263-78. ISBN 1-58829473-0. GENES NEOPLASICOS; NEOPLASIAS DE CABECA E PESCOCO; TERAPIA GENETICA; IMUNOTERAPIA |
| 474/636 | US=16 / Tórax Lonardo F, Dean S. Lung cancer biology: cell cycle alterations in lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 135-46. ISBN 0-7817-4620-5. ALTERACAO DO GENE NO CICLO CELULAR; NEOPLASIA DE PULMAO; TUMORES NEUROENDOCRINOS; CONDICOES PRE INVASIVAS; QUIMIOTERAPIA |
| 475/636 | US=16 / Tórax Beer DG. Pathology and molecular classification: molecular prognostication of lung cancer. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 270-80. ISBN 0-7817-4620-5. LUNG CANCER HETEROGENEITY; MOLECULAR PROGNOSTICATION; GENE ALTERATIONS; CYTOGENETIC ANALYSES; PATIENT SURVIVAL |
| 476/636 | US=16 / Tórax Lee CT, Carbone DP. Novel therapeutic strategies: gene therapy. In: Pass HL, Carbone DP, Johnson DH, Minna JD, Turrisi III AT. Lung Cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 734-53. ISBN 0-7817-4620-5. |
| 477/636 | US=27 / Estatistica Tabus I, Astola J. Gene feature selection. In: Dougherty ER, Shmulevich I, Chen J, Wang J. Genomic signal processing and Statistics. New York: Hindawi Publishing Corporation, 2005. p. 67-92. (Eurasip Book Series on Signal Processing and Communications, v. 2) ISBN 978-9-775-94507-5. MECANISMO GENETICO; GENES; TEOREMA DE BAYES; CENARIO REALISTICO; METODOS WRAPPER; CRITERIOS DE OTIMIZACAO; CRITERIOS DE REGULARIZACAO; PARAMETROS; DETERMINACAO DO COEFICIENTE; CRITERIO DE INFORMACAO TEORICA; METODOLOGIA DE AVALIACAO PRATICA |
| 478/636 | US=21-A / Dermatologia Zalis M, Ferreira CG. Diagnóstico e classificação molecular do melanoma. In: Wainstein AJA, Belfort FA. Melanoma: prevenção, diagnóstico, tratamento e acompanhamento. São Paulo: Atheneu, 2014. p. 183-189. ISBN 978-85-86652-31-0. MELANOMA. CLASSIFICACAO MOLECULAR; MELANOMA. DIAGNOSTICO; MELANOMA. GENETICA; MUTACAO DOS GENES ASSOCIADOS A VIA MAPK; PAPEL DO GENE BRAF; MUTACAO DO CODON V600; PAPEL DA PROTEINA CKIT NO MELANOMA; MUTACAO NO GENE MEK 1; MUTACAO EM TUMORES SOLIDOS. DIAGNOSTICO; DETECCAO DE MUTACOES POR PCR |
| 479/636 | US=120 / Câncer Guindalini RSC, Pereira GLS. Terapia gênica. In: Hoff PMG. Tratado de oncologia. São Paulo: Atheneu, 2013. p. 827-837. ISBN 85-388-0312-6. PRINCIPIOS DA TERAPIA GENICA VOLTADA AO CANCER; TERAPIA DO GENE SUICIDA; PERSPECTIVAS FUTURAS DA TERAPIA GENICA; MONITORAMENTO DA REPLICACAO VIRAL NAO INVASIVA |
| 480/636 | US=22-C / Câncer Gore SD, Baylin SB, Herman JG. inibidores de histona desacetilase e agentes de desmetilação. In: DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 10 ed. Philadelphia: Wolters Kluwer, 2015. p. 248-257. ISBN 978-1-45119294-0. ANORMALIDADES EPIGENETICAS; MUDANCAS DE EXPRESSAO GENETICA NO CANCER; SILENCIAMENTO DO GENE ANORMAL; CROMATINA NA REGULACAO DOS GENES; ENZIMAS QUE REGULAM A METILACAO DO DNA E A ACETILACAO DA HISTONA; INVERSAO DAS CAMADAS DE SILENCIAMENTO DO GENE; INIBIDORES DA DNA METILTRANSFERASE; INIBIDORES DE HISTONA DESACETILASE; TERAPIA EPIGENETICA. NEOPLASIA HEMATOLOGICA; NOVAS ABORDAGENS PARA A TERAPIA EPIGENETICA |